Is there a role for autotransplants in patients with follicular lymphoma in the rituximab era?

被引：1

作者：

Armitage, James O. ^{[1
]}

机构：

[1] Univ Nebraska Med Ctr, Omaha, NE USA

来源：

TRANSFUSION AND APHERESIS SCIENCE | 2013年 / 49卷 / 01期

关键词：

STEM-CELL TRANSPLANTATION; HIGH-DOSE THERAPY; BONE-MARROW-TRANSPLANTATION; NON-HODGKINS-LYMPHOMA; 1ST REMISSION; FOLLOW-UP; PHASE-II; CHEMOTHERAPY; SURVIVAL; MULTICENTER;

D O I：

10.1016/j.transci.2013.05.020

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Patients with low grad follicular lymphoma were shown to be able to achieve long-term disease-free survival when transplanted after relapse in the era before the wide spread use of rituximab. It appears that the availability of rituximab has not diminished the value of transplantation (i.e., either autologous or allogeneic) in the care of these patients. A similar overall survival and less treatment related toxicity make autologous transplantation the better choice for most patients transplanted at first treatment failure. (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：24 / 26

页数：3

共 24 条

[1] Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma [J].

Arcaini, L. ;

Montanari, F. ;

Alessandrino, E. P. ;

Tucci, A. ;

Brusamolino, E. ;

Gargantini, L. ;

Cairoli, R. ;

Bernasconi, P. ;

Passamonti, F. ;

Bonfichi, M. ;

Zoli, V. ;

Bottelli, C. ;

Calatroni, S. ;

Troletti, D. ;

Merli, M. ;

Pascutto, C. ;

Majolino, I. ;

Rossi, G. ;

Morra, E. ;

Lazzarino, M. .

ANNALS OF ONCOLOGY, 2008, 19 (07) :1331-1335

[2] Syngeneic hematopoietic stem-cell transplantation for Non-Hodgkin's lymphoma: A comparison with allogeneic and autologous transplantation - The lymphoma working committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation [J].

Bierman, PJ ;

Sweetenham, JW ;

Loberiza, FR ;

Taghipour, G ;

Lazarus, HM ;

Rizzo, JD ;

Schmitz, N ;

van Besien, K ;

Vase, JM ;

Horowitz, M ;

Goldstone, A .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (20) :3744-3753

[3] High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol [J].

Brice, P ;

Simon, D ;

Bouabdallah, R ;

Bélanger, C ;

Haïoun, C ;

Thieblemont, C ;

Tilly, H ;

Harousseau, JL ;

Doyen, C ;

Martin, C ;

Brousse, N ;

Solal-Céligny, P .

ANNALS OF ONCOLOGY, 2000, 11 (12) :1585-1590

[4] Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission [J].

Brown, Jennifer R. ;

Feng, Yang ;

Gribben, John G. ;

Neuberg, Donna ;

Fisher, David C. ;

Mauch, Peter ;

Nadler, Lee M. ;

Freedman, Arnold S. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (09) :1057-1065

[5] Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma:: a prospective, multicenter phase II study [J].

Brugger, W ;

Hirsch, J ;

Grünebach, F ;

Repp, R ;

Brossart, P ;

Vogel, W ;

Kopp, HG ;

Manz, MG ;

Bitzer, M ;

Schlimok, G ;

Kaufmann, M ;

Ganser, A ;

Fehnle, K ;

Gramatzki, M ;

Kanzl, L .

ANNALS OF ONCOLOGY, 2004, 15 (11) :1691-1698

[6] Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells [J].

Corradini, P ;

Dodero, A ;

Zallio, F ;

Caracciolo, D ;

Casini, M ;

Bregni, M ;

Narni, F ;

Patriarca, F ;

Boccadoro, M ;

Benedetti, F ;

Rambaldi, A ;

Gianni, AM ;

Tarella, C .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2172-2176

[7] INCIDENCE AND CHARACTERIZATION OF SECONDARY MYELODYSPLASTIC SYNDROME AND ACUTE MYELOGENOUS LEUKEMIA FOLLOWING HIGH-DOSE CHEMORADIOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR LYMPHOID MALIGNANCIES [J].

DARRINGTON, DL ;

VOSE, JM ;

ANDERSON, JR ;

BIERMAN, PJ ;

BISHOP, MR ;

CHAN, WC ;

MORRIS, ME ;

REED, EC ;

SANGER, WG ;

TARANTOLO, SR ;

WEISENBURGER, DD ;

KESSINGER, A ;

ARMITAGE, JO .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (12) :2527-2534

[8] High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS [J].

Deconinck, E ;

Foussard, C ;

Milpied, N ;

Bertrand, P ;

Michenet, P ;

Cornillet-LeFebvre, P ;

Escoffre-Barbe, M ;

Maisonneuve, H ;

Delwail, V ;

Gressin, R ;

Legouffe, E ;

Vilque, JP ;

Desablens, B ;

Jaubert, J ;

Ramee, JF ;

Jenabian, A ;

Thyss, A ;

Le Pourhiet-Le Mevel, A ;

Travade, P ;

Delepine, R ;

Colombat, P .

BLOOD, 2005, 105 (10) :3817-3823

[9] High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission [J].

Freedman, AS ;

Gribben, JG ;

Neuberg, D ;

Mauch, P ;

Soiffer, RJ ;

Anderson, KC ;

Pandite, L ;

Robertson, MJ ;

Kroon, M ;

Ritz, J ;

Nadler, LM .

BLOOD, 1996, 88 (07) :2780-2786

[10] High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years [J].

Gyan, Emmanuel ;

Foussard, Charles ;

Bertrand, Philippe ;

Michenet, Patrick ;

Le Gouill, Steven ;

Berthou, Christian ;

Maisonneuve, Herve ;

Delwail, Vincent ;

Gressin, Remi ;

Quittet, Philippe ;

Vilque, Jean-Pierre ;

Desablens, Bernard ;

Jaubert, Jerome ;

Ramee, Jean-Francois ;

Arakelyan, Nina ;

Thyss, Antoine ;

Molucon-Chabrot, Cecile ;

Delepine, Roselyne ;

Milpied, Noel ;

Colombat, Philippe ;

Deconinck, Eric .

BLOOD, 2009, 113 (05) :995-1001

← 1 2 3 →